跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Compound Paracetamol and Amantadine Hydrochloride Tablets
Approved
化学药品
Compound Paracetamol and Amantadine Hydrochloride Tablets
大同市利群药业有限责任公司
🇨🇳 National Medical Products Administration
Approval Date
Aug 31, 2020
Approval ID
7LeaeURCWh8
Company
大同市利群药业有限责任公司
Type
化学药品
Approval Details
Approval Id
7LeaeURCWh8
Approval Number
国药准字H14023284
Generic Name
复方氨酚烷胺片
Generic Name En
Compound Paracetamol and Amantadine Hydrochloride Tablets
Brand Name
利君
Drug Type
化学药品
Dosage Form
片剂
Strength
对乙酰氨基酚250mg,盐酸金刚烷胺100mg,人工牛黄10mg,咖啡因15mg,马来酸氯苯那敏2mg
Reg Date
2020-08-31
Company Name
大同市利群药业有限责任公司
Production Company Name
大同市利群药业有限责任公司
Production Company Address
山西省大同市经济技术开发区(湖东)
Company Detail Path
/organization/da-tong-shi-li-qun-yao-ye-you-xian-ze-ren-gong-si
Production Company Detail Path
/organization/da-tong-shi-li-qun-yao-ye-you-xian-ze-ren-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 31, 2020
Approval ID
7LeaeURCWh8
Type
化学药品
Back to NMPA Approvals
利君 - NMPA Drug Approval Details